Notably, endogenous GHK-Cu levels in human plasma are age-dependent, dropping from ~200 ng/mL at age 20 to below 80 ng/mL after age 60
In contrast, Wegovy comes in higher doses, aimed to produce more substantial weight loss
For something more focused, like immune support, athletic recovery, or NAD+ longevity protocols, pick the treatment that matches the goal
Well talk through the financial picture during your consultation
Scientifically Backed: The efficacy of GHK-CU is supported by extensive scientific research and clinical trials
For those looking to enhance recovery, reduce inflammation, and support gut health, BPC-157 peptide has gained attention as a promising therapeutic compound